PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,894,478 | -50.1% | 3,580,177 | -20.5% | 0.01% | -53.8% |
| Q2 2023 | $59,863,340 | -8.7% | 4,501,003 | -20.5% | 0.01% | -13.3% |
| Q1 2023 | $65,547,108 | +56.0% | 5,660,372 | +10.2% | 0.02% | +50.0% |
| Q4 2022 | $42,012,153 | +43.6% | 5,135,960 | +1.9% | 0.01% | +42.9% |
| Q3 2022 | $29,260,000 | +1463.9% | 5,040,612 | +1091.0% | 0.01% | – |
| Q2 2022 | $1,871,000 | -91.4% | 423,231 | -82.3% | 0.00% | -100.0% |
| Q1 2022 | $21,770,000 | +120.9% | 2,392,249 | +396.8% | 0.00% | +300.0% |
| Q4 2021 | $9,853,000 | -46.1% | 481,554 | -32.7% | 0.00% | -66.7% |
| Q3 2021 | $18,291,000 | -4.5% | 715,903 | +30.8% | 0.00% | -25.0% |
| Q2 2021 | $19,144,000 | -32.6% | 547,457 | -35.8% | 0.00% | -42.9% |
| Q1 2021 | $28,401,000 | +138.2% | 852,641 | +85.5% | 0.01% | +133.3% |
| Q4 2020 | $11,921,000 | +189.0% | 459,558 | +10.0% | 0.00% | +200.0% |
| Q3 2020 | $4,125,000 | +511.1% | 417,856 | +113.5% | 0.00% | – |
| Q2 2020 | $675,000 | +50.0% | 195,753 | +32.9% | 0.00% | – |
| Q1 2020 | $450,000 | +179.5% | 147,298 | +369.9% | 0.00% | – |
| Q4 2019 | $161,000 | +66.0% | 31,350 | +66.3% | 0.00% | – |
| Q3 2019 | $97,000 | -99.6% | 18,851 | -99.6% | 0.00% | -100.0% |
| Q2 2019 | $26,840,000 | +40.3% | 4,436,305 | +67.6% | 0.01% | +20.0% |
| Q1 2019 | $19,136,000 | +5936.6% | 2,646,665 | +6077.0% | 0.01% | – |
| Q4 2018 | $317,000 | -47.1% | 42,847 | -61.3% | 0.00% | – |
| Q3 2018 | $599,000 | -74.8% | 110,693 | -83.4% | 0.00% | -100.0% |
| Q2 2018 | $2,373,000 | +145.4% | 668,568 | +41.8% | 0.00% | 0.0% |
| Q1 2018 | $967,000 | +151.8% | 471,447 | +224.3% | 0.00% | – |
| Q4 2017 | $384,000 | +73.0% | 145,372 | +243.4% | 0.00% | – |
| Q3 2017 | $222,000 | +20.0% | 42,330 | -18.6% | 0.00% | – |
| Q2 2017 | $185,000 | -76.6% | 52,021 | -66.0% | 0.00% | -100.0% |
| Q1 2017 | $792,000 | +15.6% | 153,146 | -15.0% | 0.00% | 0.0% |
| Q4 2016 | $685,000 | -96.2% | 180,233 | -91.0% | 0.00% | -94.1% |
| Q3 2016 | $17,940,000 | +399.2% | 2,002,180 | +291.9% | 0.02% | +325.0% |
| Q2 2016 | $3,594,000 | +81.0% | 510,887 | +118.7% | 0.00% | +33.3% |
| Q1 2016 | $1,986,000 | -24.2% | 233,609 | +17.0% | 0.00% | 0.0% |
| Q4 2015 | $2,621,000 | +1538.1% | 199,636 | +356.4% | 0.00% | – |
| Q3 2015 | $160,000 | -51.1% | 43,746 | +5.0% | 0.00% | – |
| Q4 2014 | $327,000 | +861.8% | 41,659 | +492.9% | 0.00% | – |
| Q3 2014 | $34,000 | -87.7% | 7,026 | -84.3% | 0.00% | – |
| Q2 2014 | $276,000 | +112.3% | 44,680 | +79.6% | 0.00% | – |
| Q4 2013 | $130,000 | – | 24,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |